Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Dmitry Obolskiy, PhD

Associate Director Regulatory Affairs
QbD Group, England, United Kingdom

Dr. Dmitry Obolskiy is a Regulatory Affairs professional with over 15 years of experience in clinical development and global regulatory strategy. He currently serves as Associate Director of Regulatory Affairs at QbD Group, UK, where he leads consulting services with a strong focus on clinical trial support, including strategic planning, dossier preparation, and health authority engagement. Dmitry plays a key role in project leadership and business development, contributing to the company’s growth and client success.
His career includes senior regulatory roles at ProPharma Group, Perrigo, PAREXEL, and Mylan, where he oversaw pre- and post-authorisation submissions, lifecycle management, and compliance across diverse markets. Dmitry’s expertise spans both CMC and non-CMC domains, with a proven track record in managing complex regulatory projects, authoring briefing documents, and supporting scientific advice and orphan drug designation applications.
Holding a PhD in Pharmaceutical Chemistry and Pharmacognosy, an MSc in Drug Discovery, Dmitry combines scientific depth with strategic insight to advance access to high-quality medicines through regulatory excellence.

Presentation(s):

Email Dmitry